MarketPeel
Insider Trading Intelligence
PS

Pasha Sarraf

CUE
DIRECTOR · CUE BIOPHARMA, INC. · CIK 0002059447
FILING MIX · LIFETIME100%/0%
BUYS
7
SELLS
0
TOTAL VALUE
$99.7K
COMPANIES
1
ACTIVE SINCE
Mar 2025
HOLDINGS NOW
24,400
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Pasha Sarraf, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%+21.52%+0.70%+20.82%+20.82%
14d5+100.00%+16.23%+0.98%+15.24%+15.24%
30d5+100.00%+19.54%+1.02%+18.51%+18.51%
60d5+0.00%-7.29%-0.15%-7.14%-7.14%
90d5+0.00%-25.17%-8.01%-17.15%-17.15%
180d5+100.00%+180.24%+6.11%+174.13%+174.13%
1y5(5 pending)
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CUE · 24,400 shares · as of Jan 2, 2026
080,964161,929242,893323,8572026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
FLOW · 7 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
24,40024,400Jan 2, 2026Jan 6, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
77,148$0.30$23.2K81,377Dec 30, 2025Jan 2, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
4,229$0.31$1.3K4,229Dec 30, 2025Jan 2, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
78,116$0.31$24.3K246,440Dec 30, 2025Jan 2, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
86,947$0.32$27.6K168,324Dec 30, 2025Jan 2, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASE
77,417$0.30$23.3K323,857Dec 30, 2025Jan 2, 2026View →
CUE
CUE BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
48,80048,800Mar 10, 2025Mar 12, 2025View →
Other insiders · CUE
Loading peer insiders…
About this filer
CIK 0002059447
ROLE
Director
PRIMARY
CUE
COMPANIES
1
ACTIVE SINCE
Mar 2025
MARKETPEEL · /INSIDER/0002059447DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback